Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 714 of 767

Advanced search

🌍Nov 16, 2023Industryq32bio.comTier 1 · Company source

Q32 Bio Regains Worldwide Rights to Bempikibart (ADX-914) from Amgen

Q32 BioOriginal source

🇺🇰Nov 14, 2023CDMOquotientsciences.comTier 2 · Direct publisher

Case Study: Biochemical Assay Optimization, Validation & Application

Quotient SciencesOriginal source

🌍Nov 8, 2023Industrycytomx.comTier 1 · Company source

Conditionally activated IFNa induces an inflammatory tumor microenvironment in preclinical models and increases efficacy in combination with checkpoint blockade

CytomX TherapeuticsOriginal source

🇺🇸Nov 3, 2023CDMOnoramco.comTier 2 · Direct publisher

Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit

NoramcoOriginal source

🇺🇸Oct 30, 2023CROflorencehc.comTier 2 · Direct publisher

4 Ways Site Enablement Platforms Support The White House’s Call for a Stronger Clinical Trial Infrastructure

Florence HealthcareOriginal source

🇮🇱Oct 25, 2023Devicesmedinol.comTier 1 · Company source

Medinol Receives FDA Approval for Next Generation EluNIR-PERL™ Drug-Eluting Coronary Stent System

MedinolOriginal source

🌍Oct 25, 2023Industryq32bio.comTier 1 · Company source

Q32 Bio Appoints Saul Fink, Ph.D. as Chief Technology Officer

Q32 BioOriginal source

🇧🇷Oct 20, 2023Researchpharlab.com.brTier 2 · Direct publisher

O que é dose terapêutica e qual sua importância?

Pharlab (Brazil News)Original source

🇺🇰Oct 19, 2023CDMOquotientsciences.comTier 2 · Direct publisher

Quotient Sciences Appoints Thierry Van Nieuwenhove as CEO

Quotient SciencesOriginal source

🌍Oct 19, 2023Industrycytomx.comTier 1 · Company source

Leveraging Conditional Activation to Localize Antibody Drug Conjugates to the Tumor

CytomX TherapeuticsOriginal source

🌍Oct 18, 2023Mediavirgosvs.comTier 2 · Direct publisher

VirgoTrials: Accelerating Patient Recruitment for Clinical Trial Research

VirgoOriginal source

🇧🇷Oct 13, 2023Researchpharlab.com.brTier 2 · Direct publisher

O que são medicamentos genéricos? Eles possuem a mesma eficácia dos marca?

Pharlab (Brazil News)Original source

🇺🇸Oct 11, 2023CRObioagilytix.comTier 2 · Direct publisher

PCR as a Bioanalytical Tool for Gene and Cell Therapy

BioAgilytixOriginal source

🌍Sep 20, 2023Industryonkuretherapeutics.comTier 1 · Company source

OnKure Therapeutics Appoints Ann Howell, Pharm.D., as Vice President of Regulatory Affairs

OnKure TherapeuticsOriginal source

🌍Sep 19, 2023Industrysellaslifesciences.comTier 1 · Company source

Publications - Sellas Life Sciences

SELLAS Life SciencesOriginal source

🌍Sep 19, 2023Industrysellaslifesciences.comTier 1 · Company source

CDK9 - Sellas Life Sciences

SELLAS Life SciencesOriginal source

🌍Sep 19, 2023Industrysellaslifesciences.comTier 1 · Company source

WT1 Antigen - Sellas Life Sciences

SELLAS Life SciencesOriginal source

🇧🇷Sep 14, 2023Researchpharlab.com.brTier 2 · Direct publisher

O que é farmacovigilância?

Pharlab (Brazil News)Original source

🌍Sep 13, 2023Industryq32bio.comTier 1 · Company source

Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata

Q32 BioOriginal source

🇺🇸Sep 12, 2023CDMOkbibiopharma.comTier 2 · Direct publisher

KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing

KBI BiopharmaOriginal source

🇦🇹Aug 31, 2023Devicescontextflow.comTier 1 · Company source

Plus qu’une simple détection de nodules…

contextflow (ADVANCE Chest CT Lung)Original source

🇺🇸Aug 25, 2023Industrynurabio.comTier 1 · Company source

Nura Bio Initiates Phase I Clinical Trial for its Oral, Brain-Penetrant SARM1 Inhibitor, NB-4746

Nura BioOriginal source

🇺🇸Aug 24, 2023Researchforesitecapital.comTier 2 · Direct publisher

Thyme Care – Transforming the Oncology Patient Experience Head-On

Foresite CapitalOriginal source

🇧🇷Aug 21, 2023Researchpharlab.com.brTier 2 · Direct publisher

Medicamentos podem ser guardados fora da sua embalagem original?

Pharlab (Brazil News)Original source

🇺🇰Aug 11, 2023Industrygenialcompliance.comTier 3 · Secondary coverage

Improving Document Distribution with iPassport Document Download Links - Genial

Genial Genetics (Pathozoom AI)Original source

🇺🇸Aug 9, 2023CRObioagilytix.comTier 2 · Direct publisher

Safety and Efficacy Testing of Cell Therapies

BioAgilytixOriginal source

🇺🇰Aug 4, 2023Industrygenialcompliance.comTier 3 · Secondary coverage

The benefits of adopting a Quality Management System (QMS) in a laboratory setting - Genial

Genial Genetics (Pathozoom AI)Original source

🇺🇰Aug 1, 2023Industrygenialcompliance.comTier 3 · Secondary coverage

The importance of document control for passing inspections - Genial

Genial Genetics (Pathozoom AI)Original source

🌍Jul 25, 2023Industryperspective.comTier 1 · Company source

Perspective Group Shares First Half 2023 Placements — Perspective Group

Perspective TherapeuticsOriginal source

🇺🇸Jul 24, 2023CRObioagilytix.comTier 2 · Direct publisher

Bioanalytical Support for Gene Therapy Programs

BioAgilytixOriginal source

🌍Jul 21, 2023Industrypharmasalmanac.comTier 3 · Secondary coverage

pharma’s Almanac: How is an increased focus on patient-centric concerns influencing the way that you work?

Portage BiotechOriginal source

🌍Jul 13, 2023Industrypm360online.comTier 3 · Secondary coverage

PM360: The State of the Union in Cancer Innovation

Portage BiotechOriginal source

🌍Jul 12, 2023Industrypetros.comTier 1 · Company source

What's a Petro? — Petros® Love at First Bite

Petros PharmaceuticalsOriginal source

🌍Jul 10, 2023Industrymaxcyte.comTier 1 · Company source